Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset

Ann Neurol. 2007 Dec;62(6):666-70. doi: 10.1002/ana.21235.

Abstract

We report four heterozygous dynamin 2 (DNM2) mutations in five centronuclear myopathy patients aged 1 to 15 years. They all presented with neonatal hypotonia with weak suckling. Thereafter, their phenotype progressively improved. All patients demonstrated muscle weakness prominent in the lower limbs, and most of them also presented with facial weakness, open mouth, arched palate, ptosis, and ophthalmoparesis. Electrophysiology showed only myopathic changes, and muscle biopsies showed central nuclei and type 1 fiber hypotrophy and predominance. Our results expand the phenotypic spectrum of dynamin 2-related centronuclear myopathy from the classic mild form to the more severe neonatal phenotype.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Age of Onset
  • Breast Feeding
  • Child
  • Child, Preschool
  • Dynamin II / genetics*
  • Electrophysiology
  • Facial Muscles / physiopathology
  • Heterozygote
  • Humans
  • Infant
  • Infant, Newborn
  • Leg
  • Muscle Hypotonia / complications
  • Muscle Hypotonia / etiology
  • Muscle Hypotonia / physiopathology
  • Muscle Weakness / etiology
  • Muscle Weakness / pathology
  • Muscle Weakness / physiopathology
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / physiopathology
  • Mutation*
  • Mutation, Missense
  • Myopathies, Structural, Congenital / complications
  • Myopathies, Structural, Congenital / epidemiology*
  • Myopathies, Structural, Congenital / genetics*
  • Myopathies, Structural, Congenital / physiopathology
  • Ophthalmoplegia / etiology

Substances

  • Dynamin II